We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
1651
Lyell Immunopharma
LYEL
$337M
$37.3K ﹤0.01%
537
GCO icon
1652
Genesco
GCO
$394M
$37.2K ﹤0.01%
809
BXC icon
1653
BlueLinx
BXC
$705M
$37.2K ﹤0.01%
523
-104
-17% -$7.09K
CHS
1654
DELISTED
Chicos FAS, Inc.
CHS
$37.2K ﹤0.01%
7,558
MCB icon
1655
Metropolitan Bank Holding Corp
MCB
$1.17B
$37.1K ﹤0.01%
633
CSII
1656
DELISTED
Cardiovascular Systems, Inc.
CSII
$37.1K ﹤0.01%
2,726
NTGR icon
1657
NETGEAR
NTGR
$647M
$37.1K ﹤0.01%
2,046
MBI icon
1658
MBIA
MBI
$262M
$37K ﹤0.01%
2,883
INDI icon
1659
indie Semiconductor
INDI
$875M
$37K ﹤0.01%
6,342
LPG icon
1660
Dorian LPG
LPG
$1.95B
$36.8K ﹤0.01%
1,944
EBIX
1661
DELISTED
Ebix Inc
EBIX
$36.8K ﹤0.01%
1,845
MXCT icon
1662
MaxCyte
MXCT
$149M
$36.8K ﹤0.01%
6,739
AVD icon
1663
American Vanguard Corp
AVD
$62.8M
$36.8K ﹤0.01%
1,693
HSII
1664
DELISTED
Heidrick & Struggles
HSII
$36.7K ﹤0.01%
1,312
NAT icon
1665
Nordic American Tanker
NAT
$1.4B
$36.7K ﹤0.01%
11,986
TILE icon
1666
Interface
TILE
$2.24B
$36.7K ﹤0.01%
3,714
CFB
1667
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$36.6K ﹤0.01%
2,946
UFCS icon
1668
United Fire Group
UFCS
$1.38B
$36.6K ﹤0.01%
1,336
RYAM icon
1669
Rayonier Advanced Materials
RYAM
$570M
$36.5K ﹤0.01%
3,804
ARQT icon
1670
Arcutis Biotherapeutics
ARQT
$3.25B
$36.5K ﹤0.01%
2,466
SNCY
1671
DELISTED
Sun Country Airlines
SNCY
$36.5K ﹤0.01%
2,299
ASC icon
1672
Ardmore Shipping
ASC
$707M
$36.4K ﹤0.01%
2,529
+384
+18% +$5.1K
KIDS icon
1673
OrthoPediatrics
KIDS
$653M
$36.4K ﹤0.01%
917
MBWM icon
1674
Mercantile Bank Corp
MBWM
$1.06B
$36.4K ﹤0.01%
1,087
EQBK icon
1675
Equity Bancshares
EQBK
$1.07B
$36.4K ﹤0.01%
1,113
+320
+40% +$11.1K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.